Klemens Hoegenauer, Shaojian An, Jake Axford, Christina Benander, Christian Bergsdorf, Josephine Botsch, Suzanne Chau, César Fernández, Scott Gleim, Ulrich Hassiepen, Juerg Hunziker, Emilie Joly, Aramis Keller, Sandra Lopez Romero, Robert Maher, Anne-Sophie Mangold, Craig Mickanin, Manuel Mihalic, Philippe Neuner, Andrew W Patterson, Francesca Perruccio, Silvio Roggo, Julien Scesa, Martin Schröder, Dojna Shkoza, Binh Thai, Anna Vulpetti, Martin Renatus, John S Reece-Hoyes
Redirecting E3 ligases to neo-substrates, leading to their proteasomal disassembly, known as targeted protein degradation (TPD), has emerged as a promising alternative to traditional, occupancy-driven pharmacology. Although the field has expanded tremendously over the past years, the choice of E3 ligases remains limited, with an almost exclusive focus on CRBN and VHL. Here, we report the discovery of novel ligands to the PRY-SPRY domain of TRIM58, a RING ligase that is specifically expressed in erythroid precursor cells...
December 14, 2023: ACS Medicinal Chemistry Letters